Guaifenesin
- Product NDC
- 11673-539
- 11-digit product format
- 116730539
- Labeler code
- 11673
- Product ID
- 11673-539_465357f3-c844-b291-e063-6394a90a3bf5
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- TARGET CORPORATION
- Application
- ANDA213420
- Marketing category
- ANDA
- Marketing start
- 2024-08-01
- Substance
- GUAIFENESIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Guaifenesin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GUAIFENESIN | 600 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 495W7451VQ |
| Rxcui | 636522 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 11673-539-02 | Guaifenesin | 20 in 1 BLISTER PACK | TABLET | 20 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 11673-539 | GUAIFENESIN TABLET [TARGET CORPORATION] | 4 | Current NDC, 1 package rows | 20241226_0a0aa190-8dc7-f9cc-e063-6394a90a6078.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 11673-539-02 | 11673053902 | 20 TABLET in 1 BLISTER PACK (11673-539-02) | 20 tablet | 2024-08-01 | No | No | Historical |